Ranibizumab versus aflibercept for macular edema due to central retinal vein occlusion: 18-month results in real-life data

Citation:

Chatziralli I, Theodossiadis G, Moschos MM, Mitropoulos P, Theodossiadis P. Ranibizumab versus aflibercept for macular edema due to central retinal vein occlusion: 18-month results in real-life data. Graefe's Archive for Clinical and Experimental Ophthalmology. 2017;255:1093–1100.